F18 PET Bonescan — Customer Testimonial | GE Healthcare

F18 Sodium Flouride (NaF) is a highly sensitive bone-seeking PET Tracer. Its mechanism of uptake resembles that of Tc99 methylene diphosphonate (MDP), but with better pharmacokinetics than MDP. The pharmacokinetics of NaF, together with the morphological information from CT and functional information from PET enables better characterization of bone-lesions and bone-metastases. In this testimonial, physicians at Decatur Memorial Hospital share their experiences in incorporating F18 PET bone scan into their clinical practice. #GEHealthcare #GeneralElectric

Subscribe to GE Healthcare: https://www.youtube.com/channel/UC04R4GsgwjtoI28q7F3YrLw?sub_confirmation=1

Learn more about GE Healthcare
Website: http://www.gehealthcare.com
Facebook: https://www.facebook.com/GEHealthcare
Twitter: http://twitter.com/gehealthcare
LinkedIn: http://www.linkedin.com/company/gehealthcare

About GE Healthcare:
GE Healthcare is the $19 billion healthcare business of GE (NYSE: GE). As a leading provider of medical imaging, monitoring, biomanufacturing, and cell and gene therapy technologies, GE Healthcare enables precision health in diagnostics, therapeutics and monitoring through intelligent devices, data analytics, applications and services. With over 100 years of experience in the healthcare industry and more than 50,000 employees globally, the company helps improve outcomes more efficiently for patients, healthcare providers, researchers and life sciences companies around the world.

F18 PET Bonescan — Customer Testimonial | GE Healthcare


Leave a Reply

Your email address will not be published. Required fields are marked *

Send message via your Messenger App